Tejal Vakharia - Veradigm General Affairs
| MDRXDelisted Stock | USD 13.33 0.02 0.15% |
Executive
Tejal Vakharia is General Affairs of Veradigm
| Age | 50 |
| Phone | 800 334 8534 |
| Web | https://veradigm.com |
Tejal Vakharia Latest Insider Activity
Tracking and analyzing the buying and selling activities of Tejal Vakharia against Veradigm stock is an integral part of due diligence when investing in Veradigm. Tejal Vakharia insider activity provides valuable insight into whether Veradigm is net buyers or sellers over its current business cycle. Note, Veradigm insiders must abide by specific rules, including filing SEC forms every time they buy or sell Veradigm'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 | ||
Tejal Vakharia over a year ago Payment of 1223 shares by Tejal Vakharia of Allscripts Healthcare subject to Rule 16b-3 |
Veradigm Management Efficiency
The company has return on total asset (ROA) of 0.0216 % which means that it generated a profit of $0.0216 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0893 %, meaning that it created $0.0893 on every $100 dollars invested by stockholders. Veradigm's management efficiency ratios could be used to measure how well Veradigm manages its routine affairs as well as how well it operates its assets and liabilities.Veradigm currently holds 434.5 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Veradigm has a current ratio of 3.17, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Veradigm's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Christophe Louvion | National Research Corp | 51 | |
| Steve Lindsay | HealthEquity | N/A | |
| Richard CPA | Definitive Healthcare Corp | 55 | |
| Brad Bennion | HealthEquity | N/A | |
| RN BSN | HealthStream | 48 | |
| Ron DiSantis | Certara | N/A | |
| Max Kanevsky | Certara | N/A | |
| Kevin JD | HealthStream | 54 | |
| Arthur Newman | HealthStream | 75 | |
| Sheila MBA | Certara | N/A | |
| William Moschella | Definitive Healthcare Corp | 48 | |
| Daniel Orenstein | Health Catalyst | 54 | |
| Kevin Freeman | Health Catalyst | 51 | |
| Rebecca Adams | Forian Inc | N/A | |
| Paul Reuscher | Forian Inc | N/A | |
| Jeffrey Selander | Health Catalyst | N/A | |
| Benjamin Landry | Health Catalyst | 42 | |
| Vinitha Ramnathan | National Research Corp | N/A | |
| Kyle Salyers | Health Catalyst | N/A | |
| Amanda Flanders | Health Catalyst | N/A | |
| Adam Brown | Health Catalyst | N/A | |
Management Performance
| Return On Equity | 0.0893 | ||||
| Return On Asset | 0.0216 |
Veradigm Leadership Team
Elected by the shareholders, the Veradigm's board of directors comprises two types of representatives: Veradigm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Veradigm. The board's role is to monitor Veradigm's management team and ensure that shareholders' interests are well served. Veradigm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Veradigm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elliot Bryant, Senior Unit | ||
| Richard Poulton, Pres and CFO | ||
| Lisa CPC, Senior Officer | ||
| John Mayr, Senior Organization | ||
| Gregory Garrison, Independent Director | ||
| Rebecca Whaley, VP Marketing | ||
| MD MBA, Interim Director | ||
| John Sage, Senior Sales | ||
| Joseph Rostock, Sr CTO | ||
| Richard Elmore, Senior Strategy | ||
| Paul Lewis, Sr Mang | ||
| Leland Westerfield, Interim Officer | ||
| Thomas Langan, President Officer | ||
| Tejal Vakharia, General Affairs | ||
| Jenny Gelinas, Vice Relations | ||
| Leah Jones, Chief Officer |
Veradigm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Veradigm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0893 | ||||
| Return On Asset | 0.0216 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 395.97 M | ||||
| Shares Outstanding | 109.26 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 97.30 % | ||||
| Number Of Shares Shorted | 7.46 M | ||||
| Price To Earning | 3.87 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Veradigm Stock
If you are still planning to invest in Veradigm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Veradigm's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |